US pharma group to pay €90.5m for 8% in deal that will boost joint Lyme disease programme
Pfizer
Shares rise sharply, surging by 14.5% in early session trading
President hails ‘monumental step forward’ in battle against virus but parents have been more cautious in inoculating children
Sanofi says trials point to potential of its vaccine booster candidate against main variants of concern
Interim results from its clinical trial showed the jab is safe and highly effective, company said
Paxlovid has been available in the State for more than a month
‘Transformational’ loan will allow green energy supplier meet fast-growing demand
Waning demand threatens efforts to produce vaccine locally so perhaps education is the priority
Biggest acquisition by US pharmaceutical giant in five years
Most Read
You may also like...
Crosswords & puzzles to keep you challenged and entertained
Start The Search For Your Next Job
Audio versions of the best journalism from The Irish Times